Related Experiment Videos
Schistosomal glomerular disease (a review)
Insights
Schistosomal glomerulopathy is an immune-complex kidney disease affecting 12-15% of individuals with schistosomiasis. Antigens and antibodies form immune complexes in the glomerulus, leading to kidney damage.
Area of Science:
- Nephrology
- Immunology
- Parasitology
Background:
- Schistosomal glomerulopathy is a kidney disease associated with schistosomiasis.
- It affects 12-15% of patients with hepatosplenic schistosomiasis.
- Portal hypertension facilitates antigen-antibody complex formation in circulation.
Purpose of the Study:
- To define schistosomal glomerulopathy as an immune-complex disease.
- To describe its pathogenesis, clinical presentation, and renal pathology.
- To review the role of schistosomal antigens in glomerular injury.
Main Methods:
- Review of existing literature on schistosomal glomerulopathy.
- Analysis of pathological findings in affected individuals.
- Experimental models demonstrating immune complex deposition.
Main Results:
- Schistosomal glomerulopathy is characterized by chronic membranous-proliferative glomerulonephritis.
- Nephrotic syndrome is the common clinical presentation.
- Glomerular lesions contain schistosomal antigens, antibodies, and complement.
Conclusions:
- Schistosomal glomerulopathy is an immune-complex mediated renal disease.
- Specific treatment for schistosomiasis may not impact the course of nephropathy.
- Understanding the immunopathogenesis is crucial for managing kidney complications.
Abstract:
In this review paper schistosomal glomerulopathy is defined as an immune-complex disease. The disease appears in 12-15 per cent of the individuals with hepatosplenic schistosomiasis. Portal hypertension with collateral circulation helps the by pass of the hepatic clearance process and the parasite antigens can bind to antibodies in the circulation and be trapped in the renal glomerulus. Chronic membranous-proliferative glomerulonephritis is the most common lesion present and the nephrotic syndrome is the usual form of clinical presentation. The disease can be experimentally produced, and schistosomal antigens and antibodies, as well as complement, can be demonstrated in the glomerular lesions. Specific treatment of schistosomiasis does not seem to alter the clinical course of schistosomal nephropathy.